Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Interview with Alberto López-García – Fundación Jiménez Díaz University Hospital (IIS-FJD) Alberto is a young researcher leading an important part of the project. Alberto represents the young community of the project. One of the goals of RESILIENCE is to identify the European leaders of the future. Could you tell us a bit about yourself? I […]
